Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Outlook of Therapeutic and Diagnostic Competency of Nanobodies Against Sars-Cov-2: A Systematic Review Publisher Pubmed



Aria H1 ; Mahmoodi F2 ; Ghaheh HS3 ; Zare H5 ; Heiat M6 ; Bakherad H3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
  3. 3. Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Chemical Engineering, University of Waterloo, Waterloo, N2L3G1, Ontario, Canada
  5. 5. Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical, Sciences, Kerman, Iran
  6. 6. Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Analytical Biochemistry Published:2022


Abstract

Purpose: The newly emerged coronavirus (SARS-CoV-2) continues to infect humans, and no completely efficient treatment has yet been found. Antibody therapy is one way to control infection caused by COVID-19, but the use of classical antibodies has many disadvantages. Heavy chain antibodies (HCAbs) are single-domain antibodies derived from the Camelidae family. The variable part of these antibodies (Nanobodies or VHH) has interesting properties such as small size, identify criptic epitopes, stability in harsh conditions, good tissue permeability and cost-effective production causing nanobodies have become a good candidate in the treatment and diagnosis of viral infections. Methods: Totally 157 records (up to November 10, 2021), were recognized to be reviewed in this study. 62 studies were removed after first step screening due to their deviation from inclusion criteria. The remaining 95 studies were reviewed in details. After removing articles that were not in the study area, 45 remaining studies met the inclusion criteria and were qualified to be included in the systematic review. Results: In this systematic review, the application of nanobodies in the treatment and detection of COVID-19 infection was reviewed. The results of this study showed that extensive and sufficient studies have been performed in the field of production of nanobodies against SARS-CoV-2 virus and the obtained nanobodies have a great potential for use in patients infected with SARS-CoV-2 virus. Conclusion: According to the obtained results, it was found that nanobodies can be used effectively in the treatment and diagnosis of SARS-CoV-2 virus. © 2022 Elsevier Inc.
Related Docs
View other Related Docs
1. Nanobodies, the Potent Agents to Detect and Treat the Coronavirus Infections: A Systematic Review, Molecular and Cellular Probes (2021)
2. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
3. Nanobodies; New Molecular Instruments With Special Specifications for Targeting, Diagnosis and Treatment of Triple-Negative Breast Cancer, Cancer Cell International (2022)
4. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
5. Nanomaterials and Nanotechnology-Associated Innovations Against Viral Infections With a Focus on Coronaviruses, Nanomaterials (2020)
6. Nanobodies: A Tool to Open New Horizons in Diagnosis and Treatment of Prostate Cancer, Cancer Cell International (2021)
7. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
8. Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection, Acta Medica Indonesiana (2021)
Experts (# of related papers)
View all Related Experts
Hamid Bakherad (6)
Shahrzad Ahangarzadeh (4)
Other Related Docs
9. Sars-Cov-2 Seroprevalence Among Health-Care Workers in Isfahan, Iran, Advanced Biomedical Research (2023)
10. Saliva As a Diagnostic Specimen for Detection of Sars-Cov-2 in Suspected Patients: A Scoping Review, Infectious Diseases of Poverty (2020)
11. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
12. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
13. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
14. Hypotheses for Reactivation Recurrence and Reinfection Recurrence of Covid-19, Applied Biological Research (2021)
15. Important Roles of Oligo-And Polysaccharides Against Sars-Cov-2: Recent Advances, Applied Sciences (Switzerland) (2021)
16. Comprehensive Overview of Covid-19-Related Respiratory Failure: Focus on Cellular Interactions, Cellular and Molecular Biology Letters (2022)
17. Hyper-Immune Bovine Milk As an Immunological and Nutritional Supplement for Covid-19, Frontiers in Nutrition (2022)
18. Controlling and Prevention of Novel Coronavirus Through Health and Safety Protocols in Food: Review Article, Tehran University Medical Journal (2021)
19. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
20. A Systematic Review of the Histopathologic Survey on Skin Biopsies in Patients With Corona Virus Disease 2019 (Covid-19) Who Developed Virus or Drug-Related Mucocutaneous Manifestations, Experimental Dermatology (2021)
21. Nanosponges: An Overlooked Promising Strategy to Combat Sars-Cov-2, Drug Discovery Today (2022)
22. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
23. Differential Diagnostic Utility of Clinical Laboratory Data in Patients With Severe and Non-Severe Covid-19, Shiraz E Medical Journal (2022)
24. Aptamers, the Bivalent Agents As Probes and Therapies for Coronavirus Infections: A Systematic Review, Molecular and Cellular Probes (2020)
25. Covid-19 Vaccines: Current and Future Challenges, Frontiers in Pharmacology (2024)
26. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
27. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
28. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
29. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
30. Genetics and Genomics of Sars-Cov-2: A Review of the Literature With the Special Focus on Genetic Diversity and Sars-Cov-2 Genome Detection, Genomics (2021)
31. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
32. Chitin and Chitosan As Tools to Combat Covid-19: A Triple Approach, International Journal of Biological Macromolecules (2021)
33. Review of Proposed Different Irradiation Methods to Inactivate Food-Processing Viruses and Microorganisms, Food Science and Nutrition (2021)
34. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
35. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of Covid.19 Pandemic: A Narrative Review, International Journal of Preventive Medicine (2021)
36. The Mrna Vaccines and Their Application to Combat Infectious Diseases and Cancers: A Review Article, Journal of Isfahan Medical School (2023)
37. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
38. Efficacy and Side Effects of Sputnik V, Sinopharm and Astrazeneca Vaccines to Stop Covid-19; a Review and Discussion, Immunopathologia Persa (2021)
39. In Silico Investigation of Nanocarbon Biosensors for Diagnosis of Covid-19, Eurasian Chemical Communications (2021)
40. Quantum Dots Against Sars-Cov-2: Diagnostic and Therapeutic Potentials, Journal of Chemical Technology and Biotechnology (2022)
41. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
42. An Overview on the Genomic Characteristics of the New Coronavirus (2019-Ncov) and the Prospective in Pathogenesis and Treatment of Covid-19 Infection, Journal of Isfahan Medical School (2020)
43. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
44. Sars-Cov-2 Vaccines: A Double-Edged Sword Throughout Rapid Evolution of Covid-19, Cell Biology International (2022)
45. Vaccine Production by Recognizing the Functional Mechanisms of Covid-19, Translational Research in Urology (2020)
46. Carbon-Based Nanomaterials Against Sars-Cov-2: Therapeutic and Diagnostic Applications, OpenNano (2023)
47. Environmental Aspects of the Coronaviruses Transmission: A Narrative Review, Journal of Isfahan Medical School (2020)
48. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
49. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
50. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)